Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3553852rdf:typepubmed:Citationlld:pubmed
pubmed-article:3553852lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0015688lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0021655lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C1281901lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:3553852lifeskim:mentionsumls-concept:C0702240lld:lifeskim
pubmed-article:3553852pubmed:issue5lld:pubmed
pubmed-article:3553852pubmed:dateCreated1987-5-28lld:pubmed
pubmed-article:3553852pubmed:abstractTextRaised levels of free fatty acids (FFA) compete with glucose for utilization by insulin-sensitive tissues, and, therefore, they may induce insulin resistance in the normal subject. The influence of experimental elevations in FFA levels on glucose metabolism in native insulin-resistant states is not known. We studied seven women with moderate obesity (63% above their ideal body weight) but normal glucose tolerance with the use of the insulin clamp technique with or without an infusion of Intralipid + heparin. Upon raising plasma insulin levels to approximately 60 microU/mL while maintaining euglycemia, whole body glucose utilization (3H-3-glucose) rose similarly without (from 66 +/- 7 to 113 +/- 11 mg/min m2, P less than .02) or with (from 70 +/- 7 to 137 +/- 19 mg/min m2, P less than .02) concomitant lipid infusion. In contrast, endogenous glucose production was considerably (73%) suppressed (from 66 +/- 7 to 15 +/- 8 mg/min m2, P less than .001) during the clamp without lipid, but declined only marginally (from 70 +/- 7 to 48 +/- 7 mg/min m2, NS) with lipid administration. The difference between the control and the lipid study was highly significant (P less than .02), and amounted to an average of 3.8 g of relative glucose overproduction during the second hour of the clamp. Blood levels of lactate rose by 34 +/- 15% (.1 greater than P greater than .05) in the control study but only by 17 +/- 10% (NS) during lipid infusion. Blood pyruvate concentrations fell in both sets of experiments (by approximately 45% at the end of the study) with similar time courses.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:3553852pubmed:languageenglld:pubmed
pubmed-article:3553852pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553852pubmed:citationSubsetIMlld:pubmed
pubmed-article:3553852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553852pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553852pubmed:statusMEDLINElld:pubmed
pubmed-article:3553852pubmed:monthMaylld:pubmed
pubmed-article:3553852pubmed:issn0026-0495lld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:FerranniniEElld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:BevilacquaSSlld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:BondHHlld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:MaccaroHHlld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:BonadonnaRRlld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:BuzzigoliGGlld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:CiociaroDDlld:pubmed
pubmed-article:3553852pubmed:authorpubmed-author:GioricoM AMAlld:pubmed
pubmed-article:3553852pubmed:issnTypePrintlld:pubmed
pubmed-article:3553852pubmed:volume36lld:pubmed
pubmed-article:3553852pubmed:ownerNLMlld:pubmed
pubmed-article:3553852pubmed:authorsCompleteYlld:pubmed
pubmed-article:3553852pubmed:pagination502-6lld:pubmed
pubmed-article:3553852pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:meshHeadingpubmed-meshheading:3553852-...lld:pubmed
pubmed-article:3553852pubmed:year1987lld:pubmed
pubmed-article:3553852pubmed:articleTitleAcute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects.lld:pubmed
pubmed-article:3553852pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3553852pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3553852lld:pubmed